Page last updated: 2024-08-18

acrolein and Neoplasms

acrolein has been researched along with Neoplasms in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19902 (7.69)18.7374
1990's2 (7.69)18.2507
2000's3 (11.54)29.6817
2010's11 (42.31)24.3611
2020's8 (30.77)2.80

Authors

AuthorsStudies
Dong, Y; Li, J; Liu, Y; Tu, Y; Xiao, X; Yuan, Y; Zong, Q1
Hikisz, P; Jacenik, D1
Li, J; Li, M; Shi, X; Wang, F; Zhang, Q; Zhang, Y1
Chen, X; Lv, S; Ma, S; Si, X; Song, W; Tang, Z; Xu, Y; Zhang, Y1
Abdullah, BM; Amin, M; Shalamanova, L; Tang, S; Taylor, RL; Whitehead, KA; Wylie, S1
Bai, R; Chen, C; Du, P; Gao, F; Li, J; Liu, J; Liu, S; Liu, T; Lu, X; Ma, M; Qin, F; Wang, Y; Zhou, H1
Azzahra, VO; Murlistyarini, S; Sucahyo, A; Suratmo, S; Warsito, W1
Bergmayr, C; Buchleitner, S; Dvorak, Z; Fazekas, J; Jensen-Jarolim, E; Manzano-Szalai, K; Meitz, S; Moskovskich, A; Müller, MA; Neunkirchner, A; Roth, GA; Roth-Walter, F; Stremnitzer, C1
Go, Y; Hong, E; Jung, E; Khang, G; Lee, D; Singh, SVB; Yoo, D; Yoo, W1
Bertrand, H; Chew, EH; Dang, TM; Hayes, JD; Nagle, AA; Reddy, SA; Tajima, H; Wells, G; Wong, SC1
Diaz-Perales, A; Fuchs, HC; Gomez-Casado, C; Jensen-Jarolim, E; Kinaciyan, T; Moskovskich, A; Oida, K; Roth-Walter, F; Singer, J1
Campbell, KH; Henderson, CJ; MacLeod, AK; McLaughlin, LA; McMahon, M; Wolf, CR1
Madondo, MT; Plebanski, M; Quinn, M1
Chen, BJ; Fu, CS; Li, GH; Lou, HX; Ren, DM; Shen, T; Wang, XN1
Han, DC; Hong, SH; Ismail, IA; Kang, SM; Kwon, BM1
Pradipta, AR; Tanaka, K1
Jia, W; Kidoya, H; Sakimoto, S; Takakura, N; Yamakawa, D1
Alarcon, RA2
Aratani, Y; Furuhata, A; Kawai, Y; Toyokuni, S; Uchida, K1
Chung, YM; Kim, HJ; Kim, JS; Lee, CY; Yoo, YD1
Blaschke, G; Boos, J; Hohenlöchter, B; Jürgens, H; Rossi, R; Silies, H1
Axelrad, DA; Caldwell, JC; Morello-Frosch, RA; Woodruff, TJ1
Gori, GB; Lynch, CJ1
Iype, PT; Jacobson-Kram, D; Kolodner, K; McDiarmid, MA; Strickland, PT1

Reviews

7 review(s) available for acrolein and Neoplasms

ArticleYear
The Tobacco Smoke Component, Acrolein, as a Major Culprit in Lung Diseases and Respiratory Cancers: Molecular Mechanisms of Acrolein Cytotoxic Activity.
    Cells, 2023, 03-11, Volume: 12, Issue:6

    Topics: Acrolein; Electronic Nicotine Delivery Systems; Humans; Lung; Neoplasms; Pulmonary Disease, Chronic Obstructive; Tobacco Smoke Pollution

2023
Polyamine biomarkers as indicators of human disease.
    Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2021, Volume: 26, Issue:2

    Topics: Acrolein; Alzheimer Disease; Apoptosis; Biomarkers; Biotransformation; Cadaverine; Cell Movement; Humans; Leukocytes; Neoplasms; Periodontitis; Putrescine; Renal Insufficiency, Chronic; Spermidine; Spermine

2021
Low dose cyclophosphamide: Mechanisms of T cell modulation.
    Cancer treatment reviews, 2016, Volume: 42

    Topics: Acrolein; Adenosine Triphosphate; Animals; Antineoplastic Agents, Alkylating; Biotransformation; Cell Cycle; Cross-Linking Reagents; Cyclophosphamide; Cytotoxicity, Immunologic; DNA Damage; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neoplasms; Neoplasms, Experimental; Oxidative Stress; Prodrugs; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory

2016
Cinnamaldehyde Analogues as Potential Therapeutic Agents.
    Mini reviews in medicinal chemistry, 2017, Volume: 17, Issue:1

    Topics: Acrolein; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Humans; Hypoglycemic Agents; Molecular Structure; Neoplasms; Neuroprotective Agents

2017
Cinnamaldehydes in Cancer Chemotherapy.
    Phytotherapy research : PTR, 2016, Volume: 30, Issue:5

    Topics: Acrolein; Antineoplastic Agents; Humans; Neoplasms

2016
Unexplored Chemical Reactions of Endogenous Acrolein: Detection, Toxicity, and Biological Roles.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2017, Volume: 137, Issue:3

    Topics: Acrolein; Alzheimer Disease; Amyloid beta-Peptides; Azides; Biogenic Amines; Biomarkers; Cycloaddition Reaction; Environmental Pollutants; Imines; Molecular Imaging; Neoplasms; Oxidative Stress; Peptide Fragments

2017
Anticancer system created by acrolein and hydroxyl radical generated in enzymatic oxidation of spermine and other biochemical reactions.
    Medical hypotheses, 2012, Volume: 79, Issue:4

    Topics: Acrolein; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Humans; Hydroxyl Radical; Models, Biological; Neoplasms; Oxidation-Reduction; Oxidative Stress; Phosphoramide Mustards; Spermine

2012

Other Studies

19 other study(ies) available for acrolein and Neoplasms

ArticleYear
Cinnamaldehyde-based poly(thioacetal): A ROS-awakened self-amplifying degradable polymer for enhanced cancer immunotherapy.
    Biomaterials, 2022, Volume: 289

    Topics: Acrolein; Cell Line, Tumor; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Nanoparticles; Neoplasms; Polymers; Reactive Oxygen Species; Stimuli Responsive Polymers; Tumor Microenvironment

2022
Activatable Semiconducting Polymer Nanoinducers Amplify Oxidative Damage via Sono-Ferroptosis for Synergistic Therapy of Bone Metastasis.
    Nano letters, 2023, 08-23, Volume: 23, Issue:16

    Topics: Acrolein; Bone Neoplasms; Cell Line, Tumor; Ferroptosis; Humans; Hydrogen Peroxide; Nanoparticles; Neoplasms; Oxidative Stress; Polymers

2023
Rationally Designed Polymer Conjugate for Tumor-Specific Amplification of Oxidative Stress and Boosting Antitumor Immunity.
    Nano letters, 2020, 04-08, Volume: 20, Issue:4

    Topics: Acrolein; Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Immunity; Immunotherapy; Mice; Neoplasms; Oxidative Stress; Polyethylene Glycols; Polyglutamic Acid; Polymers; Tumor Microenvironment

2020
Carcinogenicity of acrolein, crotonaldehyde, and arecoline.
    The Lancet. Oncology, 2021, Volume: 22, Issue:1

    Topics: Acrolein; Aldehydes; Animals; Arecoline; Carcinogenicity Tests; Carcinogens, Environmental; Consensus Development Conferences as Topic; Environmental Exposure; Humans; Internet; Neoplasms; Risk Assessment; Telecommunications

2021
Hypoxia and pH co-triggered oxidative stress amplifier for tumor therapy.
    European journal of pharmacology, 2021, Aug-15, Volume: 905

    Topics: Acrolein; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Glutathione; Humans; Hydrogen-Ion Concentration; Mice; NADP; Neoplasms; Nitroimidazoles; Oxidative Stress; Reactive Oxygen Species; Tumor Hypoxia; Tumor Microenvironment

2021
Molecular Docking Compounds of Cinnamaldehyde Derivatives as Anticancer Agents.
    Asian Pacific journal of cancer prevention : APJCP, 2021, Aug-01, Volume: 22, Issue:8

    Topics: Acrolein; Antineoplastic Agents; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Docking Simulation; Molecular Structure; Neoplasms; Receptors, Cell Surface; Structure-Activity Relationship

2021
Janus-faced Acrolein prevents allergy but accelerates tumor growth by promoting immunoregulatory Foxp3+ cells: Mouse model for passive respiratory exposure.
    Scientific reports, 2017, 03-23, Volume: 7

    Topics: Acrolein; Allergens; Animals; Antibody Formation; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Hypersensitivity; Immunologic Factors; Lung; Mice; Neoplasms; NF-kappa B; Receptors, Aryl Hydrocarbon; Resveratrol; Signal Transduction; Stilbenes; T-Lymphocytes, Regulatory

2017
Acid-activatable oxidative stress-inducing polysaccharide nanoparticles for anticancer therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 01-10, Volume: 269

    Topics: Acrolein; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line; Drug Carriers; Humans; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Oxidative Stress; Polysaccharides; Prodrugs; Reactive Oxygen Species

2018
3-(2-oxoethylidene)indolin-2-one derivatives activate Nrf2 and inhibit NF-κB: potential candidates for chemoprevention.
    ChemMedChem, 2014, Volume: 9, Issue:8

    Topics: Acrolein; Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cytokines; Cytoskeletal Proteins; HEK293 Cells; Humans; Indoles; Kelch-Like ECH-Associated Protein 1; Mice; Monocytes; Neoplasms; NF-E2-Related Factor 2; NF-kappa B

2014
Immune suppressive effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: implications in cancer.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Acrolein; Animals; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Cytokines; Enzyme Activation; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Lymphocytes; Mice; Monocytes; Neoplasms; NF-kappa B; Nitric Oxide; Transcription Factor AP-1

2014
HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: Acrolein; Antineoplastic Agents; Antioxidant Response Elements; Cell Line, Tumor; Cytotoxins; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Neoplasms; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-pim-1; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction

2014
2-Methoxycinnamaldehyde inhibits tumor angiogenesis by suppressing Tie2 activation.
    Biochemical and biophysical research communications, 2011, Nov-11, Volume: 415, Issue:1

    Topics: Acrolein; Angiogenesis Inhibitors; Animals; HCT116 Cells; Humans; Mice; Mice, Inbred BALB C; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Receptor, TIE-2; Xenograft Model Antitumor Assays

2011
ISOLATION OF ACROLEIN FROM INCUBATED MIXTURES OF SPERMINE WITH CALF SERUM AND ITS EFFECTS ON MAMMALIAN CELLS.
    Archives of biochemistry and biophysics, 1964, Jul-20, Volume: 106

    Topics: Acrolein; Aldehydes; Amines; Animals; Blood; Cattle; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma 180; Spermine; Tissue Culture Techniques

1964
Formation of acrolein-derived 2'-deoxyadenosine adduct in an iron-induced carcinogenesis model.
    The Journal of biological chemistry, 2003, Dec-12, Volume: 278, Issue:50

    Topics: Acrolein; Aldehydes; Animals; Antibodies, Monoclonal; Binding, Competitive; Cattle; Cell Nucleus; Deoxyadenosines; DNA Adducts; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Ions; Iron; Lipid Peroxidation; Liver; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Chemical; Neoplasms; Oxidative Stress; Oxygen; Peroxidase; Rats; Rats, Wistar; Threonine; Thymus Gland; Time Factors

2003
The activity of 2'-benzoyloxycinnamaldehyde against drug-resistant cancer cell lines.
    Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:4

    Topics: Acrolein; Antineoplastic Agents; Apoptosis; Benzoates; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Neoplasms; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species

2007
Excretion kinetics of ifosfamide side-chain metabolites in children on continuous and short-term infusion.
    International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:5

    Topics: Acetaldehyde; Acrolein; Adolescent; Adult; Antineoplastic Agents, Alkylating; Child; Female; Humans; Ifosfamide; Infusions, Intravenous; Kidney; Male; Neoplasms; Phosphoramide Mustards

1998
Air toxics and health risks in California: the public health implications of outdoor concentrations.
    Risk analysis : an official publication of the Society for Risk Analysis, 2000, Volume: 20, Issue:2

    Topics: Acrolein; Air Pollutants; Air Pollution; Benzene; Butadienes; California; Carcinogens; Chromium; Environmental Exposure; Environmental Monitoring; Formaldehyde; Health Policy; Health Priorities; Humans; Neoplasms; Occupational Exposure; Polycyclic Compounds; Public Health; Risk Assessment; Rural Health; United States; United States Environmental Protection Agency; Urban Health; Vehicle Emissions

2000
Toward less hazardous cigarettes. Current advances.
    JAMA, 1978, Sep-15, Volume: 240, Issue:12

    Topics: Acrolein; Cardiovascular Diseases; Dose-Response Relationship, Drug; Filtration; Humans; Hydrogen Cyanide; Lung Diseases; Neoplasms; Nitrogen Oxides; Risk; Smoking; Tars

1978
Evidence for acrolein-modified DNA in peripheral blood leukocytes of cancer patients treated with cyclophosphamide.
    Mutation research, 1991, Volume: 248, Issue:1

    Topics: Acrolein; Adult; Biomarkers, Tumor; Cyclophosphamide; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoblotting; In Vitro Techniques; Leukocyte Count; Leukocytes; Male; Middle Aged; Neoplasms; Smoking; Time Factors

1991